| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.2 | 1e-08 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.18 | 1e-08 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.2 | 2e-08 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.21 | 3e-08 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.2 | 3e-08 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.19 | 4e-08 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.19 | 4e-08 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.2 | 5e-08 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.2 | 5e-08 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.18 | 6e-08 |